Heartseed Inc. (TSE: 219A)
Health Care · Biotechnology · JP
¥2,641.00
+2.40% today · +52.0% 1Y
Heartseed Inc. (TSE: 219A) operates in the Biotechnology industry within the Health Care sector. The company is valued at $381.84M and employs 43 people.
Over the last twelve months the share price has gained 52.0%, trading between 1.36K and 2.93K.
Tweenvest scores Heartseed Inc. across four factors: quality 54/100, value 68/100. Its strongest factor is value.
219A price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $381.84M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -0.75
- 52-week high
- ¥2,930.00
- 52-week low
- ¥1,365.00
- Avg volume (3M)
- —
- Shares outstanding
- 22.89M
- Employees
- 43
- Next earnings
- —
About Heartseed Inc.
Heartseed Inc. is a Japan-based company engaged in research and development of regenerative medicine products. The company has established cardiac regenerative medicine, a therapy in which microtissue derived from iPS cells is transplanted into the heart for patients with severe heart failure. Target diseases include dilated cardiomyopathy, old myocardial infarction, and dilated-phase hypertrophic cardiomyopathy.
- ISIN
- JP3765140003
- Founded
- 2015
- Listed since
- Jul 30, 2024
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Opus Genetics, Inc.NasdaqCM: IRD | $386.03M | $4.64 | -0.22% |
| Formycon AGXTRA: FYB | $384.18M | €19.46 | +2.10% |
| Kyverna Therapeutics, Inc.NasdaqGS: KYTX | $384.05M | $6.21 | -2.82% |
| Zura Bio LimitedNasdaqCM: ZURA | $383.32M | $4.00 | 0.00% |
| Beijing Luzhu Biotechnology Co., Ltd.SEHK: 2480 | $380.46M | HK$15.01 | +12.01% |
| AbClon Inc.KOSDAQ: A174900 | $379.19M | ₩25,550.00 | -8.42% |
| C4 Therapeutics, Inc.NasdaqGS: CCCC | $376.46M | $3.06 | -3.16% |
| Fennec Pharmaceuticals Inc.NasdaqCM: FENC | $375.57M | $10.72 | +0.09% |
Figures last refreshed Oct 11, 2026.